Am J Dermatopathol

1. MAHURIN H, Flanagan K, Wang Y, Ruhoy SM, et al
   Atypical Deep Penetrating Melanocytic Tumors and Melanomas With Beta Catenin Mutations. A Case Series.
   Am J Dermatopathol. 2025 Oct 17. doi: 10.1097/DAD.0000000000003131.
   

   >> Share

   
   
2. TRAN GH, Nguyen TT, Luong KA, Le TN, et al
   Histopathologic Spectrum of Primary Cutaneous T-Cell Lymphomas: Insights From a Vietnamese Case Series.
   Am J Dermatopathol. 2025 Oct 17. doi: 10.1097/DAD.0000000000003155.
   

   >> Share

   
   
3. CHANG RC, Ehyaee V, Wattar R, Braun A, et al
   Evaluation of PRAME Expression in Cases of Breast Carcinoma Metastatic to Skin.
   Am J Dermatopathol. 2025 Oct 17. doi: 10.1097/DAD.0000000000003159.
   

   >> Share

   
   

   
   Am J Ophthalmol

4. MUNKWITZ SE, Shields C, Nicola MD, Williams BK Jr, et al
   Assessment of Sensorimotor Complications after Plaque Brachytherapy for Patients with Uveal Melanoma.
   Am J Ophthalmol. 2025 Oct 14:S0002-9394(25)00546.
   

   >> Share

   
   

   
   BMC Cancer

5. SIMONYAN RM, Babayan MA, Yekmalyan HH, Simonyan SG, et al
   Thermostable enzyme isoforms, continuously producing monocomponent superoxide radicals, from human postoperative serous fluids: isolation and properties.
   BMC Cancer. 2025;25:1555.
   

   >> Share

   
   
6. SCHAGERHOLM STANEV C, Sifakis EG, Hases L, Chen X, et al
   Transcriptomic profiles of endocrine-resistant breast cancer.
   BMC Cancer. 2025;25:1556.
   

   >> Share

   
   
7. COSTA-PEREIRA JP, Macedo IF, Barbosa GA, Leitao GM, et al
   Myosteatosis is associated with advanced TNM stage and tumor features in young females with breast cancer.
   BMC Cancer. 2025;25:1576.
   

   >> Share

   
   
8. YAO G, Huang Y, Shang X, Guo L, et al
   Prediction of intraductal cancer microinfiltration based on the hierarchical fusion of peri-tumor imaging histology and dual view deep learning.
   BMC Cancer. 2025;25:1564.
   

   >> Share

   
   
9. SHARMA A, Johnson KB, Sen A, Bie B, et al
   Longitudinal multi-omics analyses of chemotherapy-induced peripheral neuropathy in response to taxanes.
   BMC Cancer. 2025;25:1591.
   

   >> Share

   
   
10. POSCHMANN L, Meier F, Eichler M, Gellrich FF, et al
    Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy - a pilot study.
    BMC Cancer. 2025;25:1599.
    

    >> Share

    
    
11. LI Y, Long X, Xie Y, Zhong X, et al
    Tropomodulin 1 is essential for chemotherapy sensitivity and associated with better outcome in triple-negative breast cancer.
    BMC Cancer. 2025;25:1594.
    

    >> Share

    
    
12. GUO X, Gong X, Yang Y, Wang L, et al
    Circumferential periareolar incision length as a risk factor for skin necrosis after nipple-sparing mastectomy with deep inferior epigastric perforator flap reconstruction.
    BMC Cancer. 2025;25:1592.
    

    >> Share

    
    

    
    Br J Dermatol

13. TRAFFORD AM, Schonmann Y, Chen TC, Egeberg A, et al
    Psoriasis and the risk of 26 cancers: pooled population-based cohort studies from Denmark, England, Israel, and Taiwan.
    Br J Dermatol. 2025 Oct 12:ljaf399. doi: 10.1093.
    

    >> Share

    
    
14. HE H, Xiao M, Song L, Tian Y, et al
    Lipidome-microbiome crosstalk as an outer niche in the skin: regulatory networks in health and disease.
    Br J Dermatol. 2025 Sep 11:ljaf353. doi: 10.1093.
    

    >> Share

    
    
15. AKINSHEMOYIN VAUGHN OL
    The Long Road to Standardization in Vulvar Lichen Sclerosus Research.
    Br J Dermatol. 2025 Oct 13:ljaf405. doi: 10.1093.
    

    >> Share

    
    
16. MELCHIONDA V, van Bodegraven B, Archer CMG, Perkins W, et al
    National epidemiology of dermatofibromasarcoma protuberans, England 2013-2022.
    Br J Dermatol. 2025 Oct 14:ljaf401. doi: 10.1093.
    

    >> Share

    
    
17. LEBWOHL MG, Blauvelt A, Bagel J, Gogineni R, et al
    Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over five years in patients living with obesity.
    Br J Dermatol. 2025 Oct 14:ljaf392. doi: 10.1093.
    

    >> Share

    
    
18. LAI P, Cao M, Li M, Jiang Y, et al
    Atopic dermatitis shares a distinct T helper 2 subset with mycosis fungoides that exhibits autonomous proliferative potential.
    Br J Dermatol. 2025 Oct 14:ljaf362. doi: 10.1093.
    

    >> Share

    
    
19. PARK JJ, Nguyen CV, Choi JN, Guitart J, et al
    Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestations.
    Br J Dermatol. 2025 Oct 15:ljaf297. doi: 10.1093.
    

    >> Share

    
    
20. MCGRATH JA
    From connective tissue builders to cellular architects: the journey of the skin fibroblast.
    Br J Dermatol. 2025 Oct 16:ljaf407. doi: 10.1093.
    

    >> Share

    
    
21. TAI MC, Wang JY, Yang CC, Tsai SJ, et al
    Zinc deficiency in bullous pemphigoid: predisposing factors, skin fragility, and renal function impact.
    Br J Dermatol. 2025 Oct 16:ljaf408. doi: 10.1093.
    

    >> Share

    
    
22. ARIAS-MERINO G, Benito-Lozano J, Gomez-Martinez M, Villaverde-Hueso A, et al
    Health-related quality-of-life evaluation in epidermolysis bullosa: a scoping review.
    Br J Dermatol. 2025;193:856-864.
    

    >> Share

    
    
23. GALILI E, Barzilai A, Lev A, Amit S, et al
    Genetic, immunological and clinical assessment of isolated chronic recalcitrant dermatophytosis: A prospective study.
    Br J Dermatol. 2025 Jul 15:ljaf269. doi: 10.1093.
    

    >> Share

    
    
24. ITO S, Kolbe L, Weets G, Rogers T, et al
    Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone.
    Br J Dermatol. 2025;193:959-967.
    

    >> Share

    
    
25. BROADAWAY KA, Sun Q, Edmiston SN, Currin KW, et al
    Genomic loci and molecular genetic mechanisms for hidradenitis suppurativa.
    Br J Dermatol. 2025;193:948-958.
    

    >> Share

    
    
26. KINSLER VA, Knopfel N, Polubothu S
    Segmental macular hyperpigmentation: new genes, new clinical implications.
    Br J Dermatol. 2025;193:987-995.
    

    >> Share

    
    
27. KINSLER VA
    Mosaic disorders affecting pigmentation - part 1: how to make a clinical diagnosis.
    Br J Dermatol. 2025;193:819-829.
    

    >> Share

    
    
28. SWIDERSKI M, Lewis S, Vinogradova Y, Ridd MJ, et al
    Incidence rates of bullous pemphigoid, herpes zoster and urticaria following the start of the COVID-19 vaccination programme in the UK: a population-based cohort study.
    Br J Dermatol. 2025;193:889-897.
    

    >> Share

    
    
29. ZHU G, Gordon S, Green AC, Martin NG, et al
    Halving of Australian children's naevus counts during 1992-2016 and change in sun behaviour.
    Br J Dermatol. 2025;193:898-906.
    

    >> Share

    
    
30. SZONDI DC, Crompton RA, Oon L, Subramaniam N, et al
    Keratinocyte arginase 1 regulates proinflammatory responses and drives re-epithelialization via lipocalin 2.
    Br J Dermatol. 2025;193:924-935.
    

    >> Share

    
    
31. DASKALOPOULOU A, Assrawi E, Diab F, Louvrier C, et al
    Low-level NLRP3 mosaicism in chronic urticarial lesions: extending the phenotypic spectrum of NLRP3-related disorders and therapeutic implications.
    Br J Dermatol. 2025;193:914-923.
    

    >> Share

    
    

    
    Cancer Res

32. ZHU XZ, Zhang HY, Zhou YF, Chen YY, et al
    Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.
    Cancer Res. 2025 Aug 18. doi: 10.1158/0008-5472.CAN-24-5002.
    

    >> Share

    
    
33. QI Z, He L, Xu Z, Luo X, et al
    PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA.
    Cancer Res. 2025 Aug 7. doi: 10.1158/0008-5472.CAN-24-4751.
    

    >> Share

    
    

    
    Clin Dermatol

34. KOSCHE C, Chio MTW, Arron ST
    Skin cancer and HIV.
    Clin Dermatol. 2025;43:690-696.
    

    >> Share

    
    
35. STAHL LS, Stander S, Zeidler C
    New definitions and subtypes of chronic prurigo.
    Clin Dermatol. 2025;43:610-613.
    

    >> Share

    
    
36. ZHAO X, Mueller JM, Mueller SM
    Functional magnetic resonance imaging in prurigo nodularis: A call to study neural sensitization phenomena.
    Clin Dermatol. 2025;43:661-668.
    

    >> Share

    
    
37. BROOKS SG, Yosipovitch G
    Evolving evidence in the neural sensitization of prurigo nodularis.
    Clin Dermatol. 2025;43:626-632.
    

    >> Share

    
    
38. GOESSINGER EV, Kliesener T, Muehleisen B, Brandt O, et al
    Prurigo nodularis imitators unmasked.
    Clin Dermatol. 2025;43:633-639.
    

    >> Share

    
    
39. BROOKS SG, Yosipovitch G
    Prurigo nodularis in 2025: Current and emerging treatments.
    Clin Dermatol. 2025;43:669-680.
    

    >> Share

    
    
40. HASHIMOTO T, Okuno S
    The big four in the pathogenesis and pathophysiology of prurigo nodularis: Interplay among type 2 inflammation, epidermal hyperplasia, dermal fibrosis, and itch from neuroimmune dysregulation.
    Clin Dermatol. 2025;43:614-625.
    

    >> Share

    
    
41. MATEEVA V, Kafelova A, Drenovska K, Vassileva S, et al
    Prurigo nodularis phenotype in the bullous dermatoses spectrum.
    Clin Dermatol. 2025;43:656-660.
    

    >> Share

    
    
42. BROOKS SG, Coscarella G, Yosipovitch G
    Prurigo Nodularis: A historic perspective.
    Clin Dermatol. 2025;43:606-609.
    

    >> Share

    
    
43. LEE HJ, Kim HS
    Prurigo nodularis and the microbiome.
    Clin Dermatol. 2025;43:649-655.
    

    >> Share

    
    
44. KOUMPRENTZIOTIS IA, Kroumpouzos E, Delavar S, Kroumpouzos G, et al
    Microneedling radiofrequency followed by topical exosome application therapy for pattern hair loss: A scoping review and prospective study.
    Clin Dermatol. 2025;43:742-751.
    

    >> Share

    
    
45. MANJUNATH J, Akinniyi BU, Kollhoff AL, Kwatra SG, et al
    Comorbidities in prurigo nodularis.
    Clin Dermatol. 2025;43:681-685.
    

    >> Share

    
    

    
    Clin Exp Dermatol

46. YEOH WC, Bakshi A, Bontea T, Nair J, et al
    Successful treatment of cutaneous collagenous vasculopathy with cyclophosphamide in a patient with granulomatosis with polyangiitis.
    Clin Exp Dermatol. 2025 Oct 16:llaf459. doi: 10.1093.
    

    >> Share

    
    
47. DI GUARDO A, Gallo U, Feresin F, Trovato F, et al
    Chronic Recurrent Dermatitis Induced by Millepora dichotoma (Fire Coral): A Case of Long Duration.
    Clin Exp Dermatol. 2025 Oct 13:llaf455. doi: 10.1093.
    

    >> Share

    
    
48. SASAKI C, Yatsuzuka K, Kohri N, Yoshida S, et al
    Generalized pustular psoriasis treated with additional biologics after spesolimab: A case series from Japan.
    Clin Exp Dermatol. 2025 Oct 13:llaf457. doi: 10.1093.
    

    >> Share

    
    
49. ATAK MF, Farabi B, Rosendahl C, Kittler H, et al
    Dermatoscopic features of labial melanotic macules in diverse skin types.
    Clin Exp Dermatol. 2025 Oct 13:llaf452. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Dermatol

50. CHIEI GALLO A, Tavoletti G, Termini D, Avallone G, et al
    Phenotypic Switch From Atopic Dermatitis to Psoriasis During Dupilumab Therapy: A Real-Life Experience From a Tertiary Referral Center.
    Int J Dermatol. 2025 Oct 16. doi: 10.1111/ijd.70105.
    

    >> Share

    
    

    
    Intern Med

51. YAMAZAKI S, Tominaga K, Watanabe K, Watanabe M, et al
    Coexistence of Relapsing Polychondritis, Crohn's Disease, and Pyoderma Gangrenosum Treated Successfully with Adalimumab: A Case Report and Literature Review.
    Intern Med. 2025;64:2971-2978.
    

    >> Share

    
    
52. OMOTO E, Sato K, Takahashi D, Kudoh K, et al
    Treatment of Desquamative Interstitial Pneumonia and Systemic Sclerosis with Corticosteroids and Immunosuppressants.
    Intern Med. 2025;64:2985-2989.
    

    >> Share

    
    
53. NAKASHIMA K, Demura Y, Kimura S, Yamaoka K, et al
    Bullous Pemphigoid in Patients with Non-small-cell Lung Cancer Complicated by Diabetes Mellitus Receiving Dipeptidyl Peptidase-4 Inhibitors and Immune Checkpoint Inhibitors: A Case Report of Two Patients and Review of Literature.
    Intern Med. 2025;64:2995-2999.
    

    >> Share

    
    
54. WATANABE H, Takahashi Y, Namiki T, Nakagawa R, et al
    Dyskeratosis Congenita Complicated by Pulmonary Fibrosis and Myelodysplastic Syndrome with a Germline Mutation of the DKC1 Gene and a Somatic Mutation of the U2AF1 Gene in Leukocytes.
    Intern Med. 2025;64:3000-3006.
    

    >> Share

    
    
55. WATANABE T, Tanaka-Mabuchi N, Morishima Y, Hata T, et al
    Intravenous Methylprednisolone for Acute Right Middle Cerebral Artery Occlusion in Granulomatosis Polyangiitis.
    Intern Med. 2025;64:3027-3032.
    

    >> Share

    
    

    
    J Cutan Pathol

56. MONTEAGUDO C, Martinez-Rodriguez M, Garcia-Gomez E, Perez-Deben S, et al
    Eccrine Coil Elastosis: A New Dermatopathological Feature Associated With Prediabetes and Diabetes.
    J Cutan Pathol. 2025;52:720-727.
    

    >> Share

    
    
57. CRAWL-BEY A, Brown RA, Moore JB
    A Rare Case of Dermal Myofibroblastoma Emphasizing the Diagnostic Utility of Immunohistochemical Loss of Rb Expression.
    J Cutan Pathol. 2025;52:667-670.
    

    >> Share

    
    
58. MENG Z, Shenk MER, Holliday D, Hunter DV, et al
    Cutaneous Clear Cell Sarcoma in the Genital Region: A Report of Two Cases at an Unusual Location.
    J Cutan Pathol. 2025 Oct 13. doi: 10.1111/cup.70001.
    

    >> Share

    
    
59. SUZUKI N, Shimauchi T, Ginoza A, Kageyama R, et al
    Utility of a Combination of Histopathological and Flow Cytometric Analyses for the Diagnosis of Cutaneous Involvement of GATA3(+) Peripheral T-Cell Lymphoma, Not Otherwise Specified.
    J Cutan Pathol. 2025;52:663-666.
    

    >> Share

    
    

    
    J Dermatol

60. HAYASHI W, Kinoshita-Ise M, Mizukawa Y, Ohyama M, et al
    Hyperpigmented Drug Eruption Caused by Sanshishi (Gardenia Fruit): A Rare and Potentially Overlooked Skin Manifestation.
    J Dermatol. 2025 Oct 10. doi: 10.1111/1346-8138.70006.
    

    >> Share

    
    
61. 
    Correction to "Safety and Effectiveness of Ixekizumab in Japanese Patients with Psoriasis Vulgaris, Psoriatic Arthritis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis: Post-marketing Surveillance".
    J Dermatol. 2025 Oct 13. doi: 10.1111/1346-8138.17976.
    

    >> Share

    
    
62. WEN W, Yang C, Lin Z
    Multiple Cutaneous Cysts in Nevoid Basal Cell Carcinoma Syndrome.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70025.
    

    >> Share

    
    
63. HATCHO Y, Kiniwa Y, Katsuie S, Kitamura S, et al
    Two Cases of BRAF V600K Melanoma With Recurrence During Adjuvant Dabrafenib Plus Trametinib Therapy.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70018.
    

    >> Share

    
    
64. WATANABE A, Kamata M, Okada Y, Suzuki S, et al
    Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study.
    J Dermatol. 2025 Oct 16. doi: 10.1111/1346-8138.70026.
    

    >> Share

    
    
65. NATSUGA K, Tsuruta D, Takashima S, Tateishi C, et al
    Efficacy and Safety of the Topical Gene Therapy Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Study of Japanese Subjects With Dystrophic Epidermolysis Bullosa.
    J Dermatol. 2025;52:1494-1502.
    

    >> Share

    
    
66. OHYAMA M, Ito T, Amoh Y, Inui S, et al
    Japanese Dermatological Association's Clinical Practice Guidelines for Alopecia Areata 2024: A Complete English Translated Version.
    J Dermatol. 2025;52:e876-e907.
    

    >> Share

    
    
67. HUANG Y, Ke C, Chen M
    Safety Assessment of Ritlecitinib Based on the FDA Adverse Event Reporting System (FAERS) Database: A Real-World Pharmacovigilance Study.
    J Dermatol. 2025;52:1561-1569.
    

    >> Share

    
    
68. ZHANG K, Qiu T, Zhou J, Gong X, et al
    Comparison of Infantile Hemangiomas in Male and Female Infants: A Prospective Study.
    J Dermatol. 2025;52:1555-1560.
    

    >> Share

    
    
69. NAIK H, Balwani M, Colwell HH, Mathias SD, et al
    The Burden of Erythropoietic Protoporphyria (EPP): Results From the EPP Life Impact and Genetic Health Trajectory (LIGHT) Study.
    J Dermatol. 2025;52:1576-1583.
    

    >> Share

    
    
70. WANG Y, Gao J, Li F, Li L, et al
    Comparative Effectiveness and Safety of Adalimumab, Secukinumab, and Upadacitinib in Psoriatic Arthritis: A Prospective Cohort Study Based on PARWCH Cohort.
    J Dermatol. 2025;52:1527-1535.
    

    >> Share

    
    
71. MORIZANE S, Mukai T, Sunagawa K, Hasui KI, et al
    Biologics and Small-Molecule Therapies in Netherton Syndrome: A Comprehensive Review.
    J Dermatol. 2025;52:1483-1493.
    

    >> Share

    
    
72. KOGA M, Yoshinaga A, Ehara Y, Tsuge I, et al
    A Retrospective Study of Diffuse Plexiform Neurofibroma With Surgical Intervention in Neurofibromatosis 1.
    J Dermatol. 2025;52:1589-1592.
    

    >> Share

    
    
73. CHEN X, Wang Z, Li X, Liu G, et al
    A Missense Variant Within the Helix Termination Motif of KRT71 Causes Autosomal Dominant Woolly Hair/Hypotrichosis in a Chinese Family.
    J Dermatol. 2025;52:1603-1607.
    

    >> Share

    
    
74. NOZAKI H, Honma M, Kishibe M, Fujita Y, et al
    Serum Anti-Drug Antibodies in Psoriasis Patients Undergoing Biologic Therapy in Real-World Clinical Practice: A Single-Center Retrospective Study.
    J Dermatol. 2025;52:1598-1602.
    

    >> Share

    
    
75. ITAMOTO S, Tu WT, Chang CY, Watanabe M, et al
    Oral Statin Therapy in KRT16- and KRT17-Associated Palmoplantar Epidermal Differentiation Disorder (Pachyonychia Congenita).
    J Dermatol. 2025;52:1608-1611.
    

    >> Share

    
    
76. KUMA Y, Kido-Nakahara M, Kuba-Fuyuno Y, Matsumoto T, et al
    Enfortumab Vedotin-Related Skin Toxicities: Insights From Clinical and Histopathological Analysis.
    J Dermatol. 2025;52:1584-1588.
    

    >> Share

    
    

    
    J Invest Dermatol

77. SENAPATI B, Raymundo JR, Makkar J, Driskell RR, et al
    KCTD1/KCTD15-mediated repression of AP-2alpha/AP-2beta is required for proper skin appendage development and epidermal homeostasis.
    J Invest Dermatol. 2025 Oct 9:S0022-202X(25)02832.
    

    >> Share

    
    
78. GHEBREHIWET-KUFLOM J, Mehta A, Lim P, Dahle S, et al
    GLP-1 Receptor Agonists as Emerging Modulators of Inflammation and Angiogenesis in Chronic Cutaneous Wound Healing.
    J Invest Dermatol. 2025 Oct 13:S0022-202X(25)02434.
    

    >> Share

    
    
79. MIZUNO Y, Umemura M, Nagasako A, Akiyama T, et al
    FAK-Dependent Reprogramming of IFN-gamma Signaling through PYK2 Co-Inhibition Sensitizes Melanoma to Immune Checkpoint Blockade.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03407.
    

    >> Share

    
    
80. PEREZ SM, Gherardini J, Vattigunta M, Gomez TG, et al
    Substance P expands proinflammatory, IL-31-secreting M2 macrophages in human skin ex vivo through neurokinin-1 receptor-mediated signaling and increased dermal periostin expression.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03409.
    

    >> Share

    
    
81. LI H, Chen Y, Su Z, Wang J, et al
    The Role of the Microenvironment on the Localization of Hair and Skin Nonuniform Pigmented Spots in Mice with a Targeted Mutation in the Endothelin B Receptor.
    J Invest Dermatol. 2025 Oct 14:S0022-202X(25)03408.
    

    >> Share

    
    

    
    PLoS One

82. LESER C, Kabashi F, Dorffner G, Zaric O, et al
    Exploring the role of routine brain imaging in detecting asymptomatic brain metastases in first diagnosed HER2-positive breast cancer.
    PLoS One. 2025;20:e0334610.
    

    >> Share

    
    
83. CHIANG MC, Chang CC, Lee CY, Yeh CC, et al
    Risk of atopic dermatitis in periodontitis patients with and without dental scaling: A retrospective cohort study.
    PLoS One. 2025;20:e0333877.
    

    >> Share

    
    
84. GUEVARA-NIETO HM, Orozco-Castano CA, Parra-Medina R, Poveda-Garavito JN, et al
    Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment.
    PLoS One. 2025;20:e0334335.
    

    >> Share

    
    
85. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    

    >> Share

    
    
86. WEI J, Li Y, Liu Y
    Association of biological age acceleration with all-cause and cardiovascular mortality in HSV-positive adults: A population-based longitudinal cohort study.
    PLoS One. 2025;20:e0334621.
    

    >> Share

    
    
87. CHOU HH, Chu PY, Wu YH, Feng C, et al
    Health impact and cost-effectiveness analysis of gender-neutral versus female-only 9-valent human papillomavirus vaccination in Taiwan.
    PLoS One. 2025;20:e0333757.
    

    >> Share

    
    
88. HEUER R, Paulmann M, Mockenhaupt M, Nast A, et al
    Epidermal necrolysis (Stevens-Johnson syndrome/ toxic epidermal necrolysis) as extensive boundary violation: A qualitative study on the illness experience and care needs of survivors in the context of the first German guideline.
    PLoS One. 2025;20:e0333636.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share